POST-TRANSPLANTATION CYCLOPHOSPHAMIDE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HIGHER-RISK MYELODYSPLASTIC SYNDROME

被引：0
|
作者：
Choi, E. -J. [1 ]
Park, H. -S. [1 ]
Lee, J. -H. [1 ]
Lee, K. -H. [1 ]
Lee, J. -H. [1 ]
机构：
[1] Univ Ulsan, Dept Hematol, Asan Med Ctr, Coll Med, Seoul, South Korea
来源：
LEUKEMIA RESEARCH | 2021年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P58
引用
下载
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [31] Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia
    Hu, Mengze
    Li, Junhui
    Hu, Tao
    Zhang, Zhaoxia
    Feng, Shunqiao
    Xuan, Litian
    Liu, Rong
    LEUKEMIA & LYMPHOMA, 2024,
  • [32] Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
    Im, Annie
    Rashidi, Armin
    Wang, Tao
    Hemmer, Michael
    MacMillan, Margaret L.
    Pidala, Joseph
    Jagasia, Madan
    Pavletic, Steven
    Majhail, Navneet S.
    Weisdorf, Daniel
    Abdel-Azim, Hisham
    Agrawal, Vaibhav
    Al-Homsi, A. Samer
    Aljurf, Mahmoud
    Askar, Medhat
    Auletta, Jeffery J.
    Bashey, Asad
    Beitinjaneh, Amer
    Bhatt, Vijaya Raj
    Byrne, Michael
    Cahn, Jean-Yves
    Cairo, Mitchell
    Castillo, Paul
    Cerny, Jan
    Chhabra, Saurabh
    Choe, Hannah
    Ciurea, Stefan
    Daly, Andrew
    Diaz Perez, Miguel Angel
    Farhadfar, Nosha
    Gadalla, Shahinaz M.
    Gale, Robert
    Ganguly, Siddhartha
    Gergis, Usama
    Hanna, Rabi
    Hematti, Peiman
    Herzig, Roger
    Hildebrandt, Gerhard C.
    Lad, Deepesh P.
    Lee, Catherine
    Lehmann, Leslie
    Lekakis, Lazaros
    Kamble, Rammurti T.
    Kharfan-Dabaja, Mohamed A.
    Khandelwal, Pooja
    Martino, Rodrigo
    Murthy, Hemant S.
    Nishihori, Taiga
    O'Brien, Tracey A.
    Olsson, Richard F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (08) : 1459 - 1468
  • [33] Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation
    Kim, Seo Yeon
    Lee, Hyewon
    Han, Mi-Soon
    Shim, Hyoeun
    Eom, Hyeon-Seok
    Park, Boram
    Kong, Sun-Young
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (09): : 527 - 535
  • [34] IMPACT OF GRAFT-VERSUS-HOST DISEASE ON OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES
    Aoki, J.
    Ishiyama, K.
    Aoki, K.
    Ishikawa, T.
    Itonaga, H.
    Fukuda, T.
    Ohashi, K.
    Iwato, K.
    Chiaki, K.
    Mori, T.
    Miyamura, K.
    Nagamura, T.
    Mori, S.
    Ichinohe, T.
    Atsuta, Y.
    Miyazaki, Y.
    HAEMATOLOGICA, 2014, 99 : 347 - 348
  • [35] Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study
    Yves Soltermann
    Dominik Heim
    Michael Medinger
    Helen Baldomero
    Jörg P. Halter
    Sabine Gerull
    Christian Arranto
    Jakob R. Passweg
    Martina Kleber
    Annals of Hematology, 2019, 98 : 1485 - 1493
  • [36] Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study
    Soltermann, Yves
    Heim, Dominik
    Medinger, Michael
    Baldomero, Helen
    Halter, Joerg P.
    Gerull, Sabine
    Arranto, Christian
    Passweg, Jakob R.
    Kleber, Martina
    ANNALS OF HEMATOLOGY, 2019, 98 (06) : 1485 - 1493
  • [37] Graft-versus-host disease prophylaxis with high-dose post-transplantation cyclophosphomide in unrelated hematopoetic stem cell transplantation
    Pirogova, O.
    Moiseev, I.
    Vavilov, V.
    Slesarchuk, O.
    Bondarenko, S.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S164 - S165
  • [38] Allogeneic Transplantation for Myelofibrosis with Novel Graft-versus-Host Disease Prophylaxis
    Volodin, Leonid
    Ballen, Karen K.
    ACTA HAEMATOLOGICA, 2021, 144 (02) : 124 - 125
  • [39] Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation
    Saberian, Chantal
    Abdel-Wahab, Noha
    Abudayyeh, Ala
    Rafei, Hind
    Joseph, Jacinth
    Rondon, Gabriela
    Whited, Laura
    Gruschkus, Stephen
    Fa'ak, Faisal
    Daher, May
    Knape, Cristina
    Safa, Houssein
    Shoukier, Mahran
    Suarez-Almazor, Maria E.
    Marcotulli, Megan
    Ludford, Kaysia
    Gulbis, Alison M.
    Konopleva, Marina
    Ohanian, Maro
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Oran, Betul
    Popat, Uday R.
    Mehta, Rotesh
    Alousi, Amin M.
    Daver, Naval
    Champlin, Richard
    Diab, Adi
    Al-Atrash, Gheath
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)
  • [40] Antithymocyte Globulin for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation
    Mohty, Mohamad
    Malard, Florent
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (36) : 3993 - +
12345